NCT01798056 2021-05-13Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving ChemotherapyGlaxoSmithKlinePhase 3 Completed237 enrolled 20 charts
NCT01767467 2018-06-06Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood CancersGlaxoSmithKlinePhase 3 Completed568 enrolled 26 charts